Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75

被引:35
作者
De Luca, Laura [1 ]
Ferro, Stefania [1 ]
Morreale, Francesca [1 ]
De Grazia, Sara [1 ]
Chimirri, Alba [1 ]
机构
[1] Univ Messina, Dipartimento Farmacochim, I-98168 Messina, Italy
关键词
antiviral agents; CHIBA-3053; CX04328; D77; LEDGF/p75; protein-protein interactions; PROTEIN-PROTEIN INTERACTIONS; SMALL-MOLECULE INHIBITORS; INTEGRASE-BINDING DOMAIN; AT-HOOK MOTIFS; COMPLEX-FORMATION; N-METHYLATION; IDENTIFICATION; DESIGN; PEPTIDE; REVEALS;
D O I
10.1002/cmdc.201100071
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The replication cycle of human immunodeficiency virus type 1 (HIV-1) is a complex multistep process that depends on both viral and host cell factors. The nuclear protein lens epithelium-derived growth factor (LEDGF/p75) is a multidomain protein, present in host cells, which plays an important role in the integration process. LEDGF/p75 not only binds HIV-1 integrase (IN) at its IN binding domain (IBD) but also contains several motifs that function in DNA and chromatin binding. The demonstrated importance of the association between IN and LEDGF/p75 in HIV-1 integration suggests the possibility that this protein-protein interaction (PPI) could be exploited as an antiviral target. We describe herein the progress to date in developing inhibitors of this promising target.
引用
收藏
页码:1184 / 1191
页数:8
相关论文
共 59 条
[51]   The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation? [J].
Stec, I ;
Nagl, SB ;
van Ommen, GJB ;
den Dunnen, JT .
FEBS LETTERS, 2000, 473 (01) :1-5
[52]   A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo [J].
Turlure, F ;
Maertens, G ;
Rahman, S ;
Cherepanov, P ;
Engelman, A .
NUCLEIC ACIDS RESEARCH, 2006, 34 (05) :1653-1665
[53]  
Valdar WSJ, 2001, PROTEINS, V42, P108
[54]   Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus [J].
Vandekerckhove, L ;
Christ, F ;
Van Maele, B ;
De Rijck, J ;
Gijsbers, R ;
Van den Haute, C ;
Witvrouw, M ;
Debyser, Z .
JOURNAL OF VIROLOGY, 2006, 80 (04) :1886-1896
[55]   Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering [J].
Vanegas, M ;
Llano, M ;
Delgado, S ;
Thompson, D ;
Peretz, M ;
Poeschla, E .
JOURNAL OF CELL SCIENCE, 2005, 118 (08) :1733-1743
[56]   Inhibitors of protein-protein interactions as potential drugs [J].
Veselovsky, Alexander V. ;
Archakov, Alexander I. .
CURRENT COMPUTER-AIDED DRUG DESIGN, 2007, 3 (01) :51-58
[57]   Zinc coupling potentiates anti-HIV-1 activity of baicalin [J].
Wang, Q ;
Wang, YT ;
Pu, SP ;
Zheng, YT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (02) :605-610
[58]   LigandScout: 3-d pharmacophores derived from protein-bound Ligands and their use as virtual screening filters [J].
Wolber, G ;
Langer, T .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2005, 45 (01) :160-169
[59]  
WOODLEY JF, 1994, CRIT REV THER DRUG, V11, P61